6-87155682-G-A

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4BS2

The NM_015021.3(ZNF292):​c.91G>A​(p.Glu31Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000557 in 1,437,196 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000056 ( 0 hom. )

Consequence

ZNF292
NM_015021.3 missense

Scores

5
5
9

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.29

Publications

0 publications found
Variant links:
Genes affected
ZNF292 (HGNC:18410): (zinc finger protein 292) This gene encodes a growth hormone-dependent, zinc finger transcription factor that functions as a tumor suppressor. Naturally occurring mutations in this gene are associated with gastric cancer, colorectal cancer, and chronic lymphocytic leukemia. [provided by RefSeq, May 2017]
ZNF292 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: Ambry Genetics, ClinGen
  • intellectual developmental disorder, autosomal dominant 64
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.3262843).
BS2
High AC in GnomAdExome4 at 8 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ZNF292NM_015021.3 linkc.91G>A p.Glu31Lys missense_variant Exon 1 of 8 ENST00000369577.8 NP_055836.1 O60281-1
ZNF292NM_001351444.2 linkc.-475G>A 5_prime_UTR_variant Exon 1 of 9 NP_001338373.1
ZNF292XM_047418459.1 linkc.-643G>A 5_prime_UTR_variant Exon 1 of 10 XP_047274415.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ZNF292ENST00000369577.8 linkc.91G>A p.Glu31Lys missense_variant Exon 1 of 8 1 NM_015021.3 ENSP00000358590.3 O60281-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
203424
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000557
AC:
8
AN:
1437196
Hom.:
0
Cov.:
31
AF XY:
0.00000421
AC XY:
3
AN XY:
712602
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33068
American (AMR)
AF:
0.00
AC:
0
AN:
41142
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25584
East Asian (EAS)
AF:
0.00
AC:
0
AN:
38634
South Asian (SAS)
AF:
0.00
AC:
0
AN:
82540
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50464
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4494
European-Non Finnish (NFE)
AF:
0.00000726
AC:
8
AN:
1101884
Other (OTH)
AF:
0.00
AC:
0
AN:
59386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
May 04, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.91G>A (p.E31K) alteration is located in exon 1 (coding exon 1) of the ZNF292 gene. This alteration results from a G to A substitution at nucleotide position 91, causing the glutamic acid (E) at amino acid position 31 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.032
T
BayesDel_noAF
Benign
-0.28
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.095
T;T;T;T
Eigen
Uncertain
0.22
Eigen_PC
Uncertain
0.28
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.88
D;T;D;T
M_CAP
Pathogenic
0.65
D
MetaRNN
Benign
0.33
T;T;T;T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
1.0
.;L;.;.
PhyloP100
2.3
PrimateAI
Pathogenic
0.86
D
PROVEAN
Uncertain
-4.0
D;N;N;N
REVEL
Benign
0.11
Sift
Pathogenic
0.0
D;D;D;D
Sift4G
Pathogenic
0.0
D;T;D;T
Polyphen
0.80
.;P;.;.
Vest4
0.44
MutPred
0.38
Gain of MoRF binding (P = 0.0036);Gain of MoRF binding (P = 0.0036);Gain of MoRF binding (P = 0.0036);Gain of MoRF binding (P = 0.0036);
MVP
0.12
ClinPred
0.97
D
GERP RS
4.5
PromoterAI
0.051
Neutral
Varity_R
0.34
gMVP
0.53
Mutation Taster
=62/38
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1220119218; hg19: chr6-87865400; API